Klöckner Pentaplast announces new lamination facility plan
The Klöckner Pentaplast Group (kpfilms.com) announced plans to expand its high-barrier film lamination and coating capacities to reinforce the company’s commitment to the global pharmaceutical and medical industries. Beginning early 2017, Klöckner Pentaplast will use a state-of-the-art system to produce Aclar® laminated pharmaceutical films from its site in Montabaur,Germany, a trusted source of high quality kp films for many industries. The new Montabaur line will be fully operational for the entire kp Pentapharm® Aclar® product range by the end of 2017.
As a result of this investment, the Klöckner Pentaplast facility in Bern, Switzerland, will also have added capacity available to produce PVdC-coated high-barrier pharmaceutical films, while continuing to be a backup site for Aclar® lamination. The plan strengthens kp’s dedication to its global packaging customers by providing improved customer service and security of supply from multiple sites under a global DMF.
“This capacity expansion is part of Klöckner Pentaplast’s long-term strategy to leverage our global footprint to maximize improvements across the value chain, with a focus on being even more responsive to our pharmaceutical customers’ needs now and in the future,“ says Markus Pischulti, business director, Pharmaceutical Films EMEA.